Watch as renowned retina specialists David A. Eichenbaum, MD and Ferhina S. Ali, MD, MPH, FASRS delve into innovative strategies designed to reduce the treatment burden for patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Adding a personal touch, a patient will share her compelling treatment journey and the profound impact of nAMD on her life. The panel will also provide practical tips on integrating these new strategies into clinical practice, ensuring you leave with actionable insights to enhance patient care.
Upon completion of this activity, participants should be better able to:
President
Retina Consultants of Tampa Bay
St. Petersburg, FL
Assistant Professor, Ophthalmology
Valhalla, NY
Physician and Surgeon, Vitreoretinal
Westchester Medical Center/Advanced Physician Services
Hawthorne, NY
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Ferhina S. Ali, MD, MPH, FASRS, has relevant financial relationships with 4D Molecular Therapeutics, AbbVie/Allergan, Adverum, Apellis, Astellas, EyePoint, Genentech, OcuTerra, Optomed, Ophthea, Regeneron (Consultant); Apellis, Astellas (Speaker).
David A. Eichenbaum, MD, has relevant financial relationships with 4D Molecular Therapeutics, AbbVie, Amaros, Annexon, ANI, Apelas, Astellas, Bausch & Lomb, Bayer, Boehringer-Ingelheim, Coherus, Complement Therapeutics, CorEvitas, Crinetics, EcoR1, EyeBio, EyePoint, Gemini, Genentech, Harrow, Kodiak, Kriya, Neurotech, Notal Vision, Novartis, Ocular Therapeutix, Oculis, Ocuphire, Orasis, Outlook, Recens Medical, Regeneron, Regenxbio, Revive, RetinAI, Roche, Samsara, Stealth, Tilack, Unity (Consultant); 4D Molecular Therapeutics, Alexion, Annexon , Astellas, Aviceda, Bayer, Boehringer-Ingelheim, EyeBio, EyePoint, Gemini, Genentech, Gyroscope, Ionis, Janssen, Kodiak, Kyowa Kirin, Novartis, Ocular Therapeutix, Ocuterra, Ollin, Opthea, ONL, Priovant, Recens Medical, Regeneron, Regenxbio, RetinAI, Roche, Stealth, Unity (Grants/Research Support); Apellis, Astellas, Bayer, Genentech, Regeneron (Speaker); 4D Molecular Therapeutics, EyePoint, Janssen (Stock/Shareholder).
Patient participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 67% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
Users must:
There is no fee to participate.
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card
Rules and Regulations
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation form and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
